시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
디지털 병리 솔루션 시장 분석 및 예측(-2034년) : 유형, 제품, 서비스, 기술, 구성 요소, 용도, 배포, 최종 사용자
Digital Pathology Solutions Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, Deployment, End User
상품코드 : 1762112
리서치사 : Global Insight Services LLC
발행일 : 2025년 07월
페이지 정보 : 영문 351 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,750 ￦ 6,656,000
Single User License help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능하며, 인쇄는 가능합니다.
US $ 5,750 ￦ 8,058,000
Site License help
PDF, Excel 보고서를 동일 기업(국가)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,750 ￦ 9,459,000
Enterprise License help
PDF, Excel 보고서를 동일 기업의 전 세계 모든분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

디지털 병리 솔루션 시장은 2024년 11억 달러에서 2034년에는 38억 달러로 확대되며 CAGR은 약 12.8%를 나타낼 것으로 전망됩니다. 이 시장은 이미지 분석 소프트웨어, 클라우드 스토리지, AI 구동 진단을 통합하여 워크플로우의 효율성과 병리학 의사 간의 협업을 개선합니다.

업계 개요

디지털 병리 솔루션 시장은 세계의 관세, 지정학적 긴장, 진화하는 공급망 역학의 영향을 복잡하게 받고 있습니다. 중국은 엄격한 수출 규제 하에서 자립적인 디지털 건강 기술로의 전환을 가속화하고 있으며 대만은 지역 긴장에 취약하지만 매우 중요한 지역입니다. 세계적으로 디지털 병리 솔루션 시장은 기술의 진보와 정밀의료에 대한 수요 증가에 의해 강력한 성장을 이루고 있습니다. 또한 중동 분쟁은 세계 공급망을 혼란시키고 에너지 가격과 운영 비용에 영향을 미치며 시장 역학과 전략적 계획에 더욱 영향을 줄 수 있습니다.

시장 세분화
유형 전체 슬라이드 이미징, 텔레병리, 이미지 분석
제품 스캐너, 소프트웨어, 스토리지 시스템
서비스 컨설팅 서비스, 통합 서비스, 유지보수 서비스
기술 인공지능, 머신러닝, 딥러닝
구성 요소 하드웨어, 소프트웨어, 서비스
용도 질병 진단, 신약 개발, 학술 연구
배포 온프레미스, 클라우드 기반, 하이브리드
최종 사용자 병원, 진단 실험실, 제약 회사, 학술 기관

시장 개요 :

디지털 병리 솔루션 시장은 주로 임상 및 연구 환경에서 디지털 이미지 처리 및 분석 기술의 채용 증가로 견조한 확대를 이루고 있습니다. 소프트웨어 분야도 병리학자가 AI와 머신러닝을 활용하여 진단 인사이트를 향상시킬 수 있기 때문에 기세를 늘리고 있습니다. 또한 원격진찰과 공동작업을 촉진함으로써 큰 영향을 줄 가능성을 제공합니다. 또한, 맞춤형 의료에 대한 주목 증가와 디지털 병리 진단과 다른 진단 모달리티의 통합이 이 시장의 향후 성장을 가속할 것으로 보입니다.

충돌 개요 :

디지털 병리 솔루션 시장은 주로 홀 슬라이드 이미징 시스템이 지배적이며 이미지 분석 플랫폼과 스토리지 시스템이 이어지고 있습니다. 효율적인 진단 툴에의 요구의 고조의 영향을 받고 있습니다. 지역별로는 북미가 시장 개척의 주도적 지위를 유지하고 있습니다만, 유럽과 아시아태평양에서는 기술 투자와 인프라 정비가 급증하고 있습니다. Biosystems, Philips Healthcare, Roche 등 주요 업계 기업은 전략적 파트너십과 지속적인 혁신을 통해 시장에서의 존재감을 높이고 있습니다. 진단의 정확성과 접근성에 혁명을 가져올 것으로 기대되고 있으며, 미래의 전망은 낙관적입니다. 그러나 데이터 프라이버시에 대한 우려나 도입 비용의 높이 등의 과제도 남아 있습니다.

주요 동향과 촉진요인 :

디지털 병리 솔루션 시장은 기술의 진보와 효율적인 진단 도구에 대한 수요 증가에 힘입어 강력한 성장을 이루고 있습니다. 또 다른 큰 동향은 클라우드 기반 솔루션의 채택이 증가하고 있다는 것입니다. 시장 성장 촉진요인으로는 만성 질환과 암의 유병률이 상승하고 진단 방법의 개선이 필요하다는 것을 들 수 있습니다. 비용 효율적이고 혁신적인 디지털 병리 솔루션을 제공할 수 있는 기업은 큰 시장 점유율을 획득할 수 있을 것으로 보입니다.

억제와 도전 :

디지털 병리 솔루션 시장에는 몇 가지 현저한 억제요인과 과제가 존재합니다. 또한 다양한 디지털 병리 플랫폼 간에 표준화가 진행되지 않아 상호 운용성 문제가 발생하고 데이터 교환이 복잡해지고 있습니다. 또한 기존의 기술에 익숙한 병리 의사가 충분한 교육이나 지원을 받지 않고 디지털 시스템으로 전환하는 것에 저항을 느낄 수 있습니다. 견고한 사이버 보안 대책이 필요하며 그 도입에는 비용과 복잡성이 수반되므로 데이터 보안과 프라이버시에 대한 우려도 근본적입니다.

목차

제1장 디지털 병리 솔루션 시장 개요

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 디지털 병리 솔루션 시장 전망

제5장 디지털 병리 솔루션 시장 전략

제6장 디지털 병리 솔루션 시장 규모

제7장 디지털 병리 검사 솔루션 시장 : 유형별

제8장 디지털 병리 솔루션 시장 : 제품별

제9장 디지털 병리 솔루션 시장 : 서비스별

제10장 디지털 병리 솔루션 시장 : 기술별

제11장 디지털 병리 솔루션 시장 : 구성 요소별

제12장 디지털 병리 솔루션 시장 : 용도별

제13장 디지털 병리 솔루션 시장 : 배포별

제14장 디지털 병리 솔루션 시장 : 최종 사용자별

제15장 디지털 병리 솔루션 시장 : 지역별

제16장 경쟁 구도

제17장 기업 프로파일

KTH
영문 목차

영문목차

Digital Pathology Solutions Market is anticipated to expand from $1.1 billion in 2024 to $3.8 billion by 2034, growing at a CAGR of approximately 12.8%. Digital Pathology Solutions Market encompasses platforms and tools that digitize pathology slides, facilitating remote analysis and enhanced diagnostic accuracy. This market integrates image analysis software, cloud storage, and AI-driven diagnostics, offering improved workflow efficiencies and collaboration among pathologists. With rising demand for precision medicine and telepathology, the market is poised for significant growth, driven by technological advancements and increasing healthcare digitization.

Industry Overview:

The Digital Pathology Solutions Market is intricately influenced by global tariffs, geopolitical tensions, and evolving supply chain dynamics. Japan and South Korea are increasingly investing in domestic R&D to mitigate tariff-induced costs on imported digital pathology equipment. China, under stringent export controls, is accelerating its transition to self-reliant digital health technologies, while Taiwan remains a pivotal player, albeit vulnerable to regional tensions. Globally, the digital pathology market is witnessing robust growth driven by technological advancements and a rising demand for precision medicine. By 2035, the market is expected to be shaped by strategic regional collaborations and innovation. Additionally, Middle East conflicts could disrupt global supply chains, affecting energy prices and operational costs, further influencing market dynamics and strategic planning.

Market Segmentation
TypeWhole Slide Imaging, Telepathology, Image Analysis
ProductScanners, Software, Storage Systems
ServicesConsulting Services, Integration Services, Maintenance Services
TechnologyArtificial Intelligence, Machine Learning, Deep Learning
ComponentHardware, Software, Services
ApplicationDisease Diagnosis, Drug Discovery, Academic Research
DeploymentOn-premise, Cloud-based, Hybrid
End UserHospitals, Diagnostic Laboratories, Pharmaceutical Companies, Academic Institutes

Market Overview:

The Digital Pathology Solutions Market is experiencing robust expansion, primarily driven by the increasing adoption of digital imaging and analysis technologies in clinical and research settings. The hardware segment, particularly digital scanners, leads the market due to their critical role in digitizing pathological slides with high precision and efficiency. This segment's dominance is attributed to technological advancements in imaging resolution and speed, which facilitate enhanced diagnostic accuracy and workflow efficiency. The software segment, encompassing image analysis and management platforms, is also gaining momentum as it enables pathologists to leverage AI and machine learning for improved diagnostic insights. Emerging sub-segments such as cloud-based digital pathology solutions are gaining traction due to their scalability and ease of integration, offering potential for significant impact by facilitating remote consultations and collaborations. Furthermore, the increasing focus on personalized medicine and the integration of digital pathology with other diagnostic modalities are set to drive future growth in this market.

Geographical Overview:

The digital pathology solutions market is witnessing considerable growth across various regions, each exhibiting unique characteristics. North America leads the charge, propelled by technological advancements and substantial investments in healthcare infrastructure. The region's focus on precision medicine and personalized healthcare further bolsters the market. Europe follows closely, with strong regulatory frameworks and a robust healthcare ecosystem driving adoption. The emphasis on early diagnosis and preventative care enhances market dynamics. In the Asia Pacific region, the market is expanding rapidly due to increasing healthcare expenditure and technological innovation. The demand for efficient diagnostic tools and telepathology services is rising, driven by an aging population. Latin America is an emerging market, with growing investments in healthcare infrastructure and digital transformation initiatives. The region's focus on improving healthcare accessibility and quality fuels market growth. The Middle East & Africa are also recognizing the potential of digital pathology solutions. Investments in healthcare modernization and the adoption of cutting-edge technologies are contributing to market expansion. The emphasis on enhancing diagnostic accuracy and reducing turnaround times is pivotal. Each region presents distinct opportunities and challenges, shaping the global digital pathology solutions market landscape.

Competition Overview:

The digital pathology solutions market is primarily dominated by whole slide imaging systems, with image analysis platforms and storage systems following closely. This hierarchy is influenced by advancements in imaging technology and the growing need for efficient diagnostic tools in pathology labs. Geographically, North America maintains a leadership position in market adoption, while Europe and the Asia-Pacific region are witnessing a surge in technological investments and infrastructure development. Key industry players such as Leica Biosystems, Philips Healthcare, and Roche are enhancing their market presence through strategic partnerships and continuous innovation. Regulatory frameworks, particularly in North America and Europe, are pivotal in setting industry standards and shaping the trajectory of market expansion. The future outlook is optimistic, with anticipated growth driven by the integration of artificial intelligence and telepathology, which are expected to revolutionize diagnostic precision and accessibility. However, challenges such as data privacy concerns and the high cost of implementation remain. Nonetheless, ongoing advancements in AI and machine learning present significant opportunities for market evolution.

Recent Developments:

The Digital Pathology Solutions Market has witnessed significant developments over the past three months, reflecting a dynamic landscape of innovation and strategic movements. Philips announced a strategic partnership with Proscia to integrate AI-driven analytics into their pathology platforms, enhancing diagnostic precision and workflow efficiency. Roche Diagnostics unveiled its latest digital pathology scanner, promising unprecedented image clarity and speed, positioning itself as a leader in pathology innovations. In a significant merger, Leica Biosystems acquired a leading AI pathology software company, expanding its digital pathology portfolio and enhancing its AI capabilities. The FDA has granted approval to a novel digital pathology solution by Olympus, marking a milestone in regulatory acceptance and paving the way for broader adoption in clinical settings. Finally, Sectra and Agfa HealthCare have entered into a joint venture to develop cloud-based pathology solutions, aiming to streamline data sharing and improve collaborative diagnostics across healthcare networks. These developments underscore the robust growth and transformative potential within the digital pathology sector.

Key Companies:

Visiopharm, Indica Labs, Optra SCAN, Hamamatsu Photonics, Inspirata, Proscia, Path AI, Sectra, Corista, Glencoe Software, Objective Pathology Services, Visi Cell Medical, Motic Digital Pathology, 3D HISTECH, Mikroscan Technologies, Paige, Huron Digital Pathology, Konfoong Biotech International, Grundium, Deep Bio

Key Trends and Drivers:

The Digital Pathology Solutions Market is experiencing robust growth, propelled by technological advancements and increasing demand for efficient diagnostic tools. A key trend is the integration of artificial intelligence and machine learning, enhancing diagnostic accuracy and enabling faster decision-making processes. This integration is streamlining workflows and facilitating the handling of large volumes of data, which is crucial for pathologists. Another significant trend is the increasing adoption of cloud-based solutions. These solutions offer scalability and flexibility, allowing for remote access to pathology data and collaboration among healthcare professionals. This is particularly beneficial in a post-pandemic world where remote work and telemedicine have become more prevalent. Market drivers include the rising prevalence of chronic diseases and cancer, necessitating improved diagnostic methods. The demand for personalized medicine is also pushing the adoption of digital pathology, as it offers precise and tailored treatment options. Furthermore, regulatory approvals for digital pathology systems are expanding, providing a conducive environment for market growth. Opportunities are abundant in emerging markets where healthcare infrastructure is evolving rapidly. Companies that can provide cost-effective and innovative digital pathology solutions stand to gain significant market share. Additionally, partnerships with healthcare institutions to enhance training and adoption of digital pathology systems present lucrative prospects for growth.

Restraints and Challenges:

The Digital Pathology Solutions Market encounters several prominent restraints and challenges. A primary challenge is the high initial investment required for digital pathology systems, which can deter smaller laboratories and institutions from adoption. Additionally, there is a significant lack of standardization across different digital pathology platforms, leading to interoperability issues and complicating data exchange. Regulatory hurdles also pose a substantial barrier, as varying compliance requirements across regions can delay product launches and increase costs. Furthermore, the market faces resistance from pathologists accustomed to traditional methods, who may be reluctant to transition to digital systems without adequate training and support. Finally, data security and privacy concerns persist, as the handling of sensitive patient information necessitates robust cybersecurity measures, which can be costly and complex to implement. These challenges collectively impede the market's growth and broader acceptance.

Research Scope:

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Digital Pathology Solutions Market Overview

2: Executive Summary

3: Premium Insights on the Market

4: Digital Pathology Solutions Market Outlook

5: Digital Pathology Solutions Market Strategy

6: Digital Pathology Solutions Market Size

7: Digital Pathology Solutions Market, by Type

8: Digital Pathology Solutions Market, by Product

9: Digital Pathology Solutions Market, by Services

10: Digital Pathology Solutions Market, by Technology

11: Digital Pathology Solutions Market, by Component

12: Digital Pathology Solutions Market, by Application

13: Digital Pathology Solutions Market, by Deployment

14: Digital Pathology Solutions Market, by End User

15: Digital Pathology Solutions Market, by Region

16: Competitive Landscape

17: Company Profiles

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기